🩸 𝐁𝐋𝐎𝐎𝐃 𝐂𝐎𝐌𝐏𝐎𝐍𝐄𝐍𝐓 𝐒𝐄𝐏𝐀𝐑𝐀𝐓𝐈𝐎𝐍

Introduction

• Blood component separation is the process of separating whole blood into its individual components so that each component can be used for specific therapeutic purposes. This practice maximizes the utilization of a single unit of donated blood and improves patient care.
• Instead of transfusing whole blood, only the required blood component is administered to the patient.

Definition

Blood component separation is the process by which whole blood is divided into various components such as Red Blood Cells (RBCs), Platelets, Plasma, and Cryoprecipitate using centrifugation techniques.

Principle

The principle of blood component separation is based on the difference in specific gravity (density) of blood components.

When blood is centrifuged:
- Red Blood Cells settle at the bottom.
- White Blood Cells and Platelets form the buffy coat layer.
- Plasma remains at the top.

Objectives of Blood Component Separation

1. Optimum Utilization of Blood
One donor unit can benefit multiple patients.
2. Reduce Transfusion Reactions
Patients receive only the required component.
3. Increase Storage Life
Each component can be stored under optimal conditions.
4. Improve Patient Management
Specific therapy can be provided according to clinical needs.

Requirements for Component Preparation

Equipment
- Refrigerated Centrifuge
- Blood Collection Bags
- Plasma Extractor
- Tube Sealer
- Deep Freezer
- Blood Bank Refrigerator
Anticoagulants Used
- CPDA-1
- CPD
- SAGM

Blood Components Obtained

1. Packed Red Blood Cells (PRBC)
Preparation
Obtained after removal of plasma from whole blood.
Storage Temperature
2°C to 6°C
Shelf Life
35–42 days
Clinical Uses
- Severe anemia
- Acute blood loss
- Surgical patients
2. Platelet Concentrate
Preparation
Prepared from platelet-rich plasma or buffy coat.
Storage Temperature
20°C to 24°C with continuous agitation
Shelf Life
5–7 days
Clinical Uses
- Thrombocytopenia
- Dengue fever
- Leukemia
- Chemotherapy patients
3. Fresh Frozen Plasma (FFP)
Preparation
Plasma separated and frozen within 6–8 hours of collection.
Storage Temperature
Below –30°C
Shelf Life
Up to 1 year
Clinical Uses
- Coagulation factor deficiency
- Liver disease
- Disseminated Intravascular Coagulation (DIC)
- Massive transfusion
4. Cryoprecipitate
Preparation
Prepared by thawing FFP at 1–6°C.
Contains
- Fibrinogen
- Factor VIII
- Factor XIII
- von Willebrand Factor
Clinical Uses
- Hemophilia A
- Hypofibrinogenemia
- von Willebrand Disease

Methods of Blood Component Separation

A. Differential Centrifugation
Most commonly used method.
♦Soft Spin
Produces:
- Platelet Rich Plasma (PRP)
- Red Blood Cells
♦Hard Spin
Produces:
- Platelet Concentrate
- Platelet Poor Plasma
B. Apheresis
Automated technique.
Specific blood component is collected while remaining components are returned to the donor.
Types
- Plateletpheresis
- Plasmapheresis
- Leukapheresis
- Erythrocytapheresis

Steps of Blood Component Separation

Step 1
Collection of whole blood from donor.
Step 2
Blood is transferred to component preparation room.
Step 3
Soft spin centrifugation performed.
Step 4
Plasma separated from RBCs.
Step 5
Hard spin centrifugation of plasma.
Step 6
Platelets separated from plasma.
Step 7
Components stored under recommended conditions.

Advantages

✅ Better utilization of donated blood
✅ Reduced risk of circulatory overload
✅ Specific component therapy
✅ Improved patient outcomes
✅ Increased availability of blood products

Quality Control of Blood Components

PRBC
- Hematocrit monitoring
- Volume assessment
Platelets

- Platelet count
- pH monitoring
FFP
- Factor VIII activity
Cryoprecipitate
- Fibrinogen content

Clinical Significance

Blood component therapy has revolutionized modern transfusion medicine by allowing targeted treatment of patients while conserving valuable blood resources.
It plays a crucial role in:
- Trauma care
- Oncology
- Hematology
- Surgery
- Intensive Care Units (ICUs)